Published in N Engl J Med on March 18, 1993
Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995. CMAJ (2000) 1.72
Cost of managing complications resulting from type 2 diabetes mellitus in Canada. BMC Health Serv Res (2003) 1.42
Physician use in Ontario and the United States: The impact of socioeconomic status and health status. Am J Public Health (1996) 1.34
Impact of managed care on the treatment, costs, and outcomes of fee-for-service Medicare patients with acute myocardial infarction. Health Serv Res (2004) 1.27
Do hospitals provide lower quality care on weekends? Health Serv Res (2007) 1.23
Do physicians do what they say? The inclination to test and its association with coronary angiography rates. J Gen Intern Med (1997) 1.22
Acute myocardial infarction in Canada: improvement with time. CMAJ (2000) 1.14
Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction. CMAJ (2001) 1.04
Survival rates for four forms of cancer in the United States and Ontario. Am J Public Health (1997) 1.04
Hospital mortality of acute myocardial infarction in the thrombolytic era. Heart (1999) 0.95
Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II. Can J Cardiol (2007) 0.94
The effect of place of residence on access to invasive cardiac services following acute myocardial infarction. Can J Cardiol (2009) 0.92
Acute ischemic heart disease and interventional cardiology: a time for pause. BMC Med (2006) 0.91
Northern exposure--can the United States learn from Canada? N Engl J Med (1993) 0.91
Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest. CMAJ (2007) 0.90
Practice variations, chance and quality of care. CMAJ (1998) 0.89
Utilisation of coronary angiography after acute myocardial infarction in Ontario over time: have referral patterns changed? Heart (2002) 0.88
Benchmarking the provision of coronary artery surgery. CMAJ (1998) 0.87
Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis. J Epidemiol Community Health (2005) 0.87
Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysis. Can J Gastroenterol (2007) 0.86
Outcomes research in the development and evaluation of practice guidelines. BMC Health Serv Res (2002) 0.85
Medical spending differences in the United States and Canada: the role of prices, procedures, and administrative expenses. Inquiry (2010) 0.84
Predictors of physical and mental health-related quality of life outcomes among myocardial infarction patients. BMC Cardiovasc Disord (2013) 0.81
Should all patients undergo cardiac catheterization after a myocardial infarction? J Nucl Cardiol (1998) 0.79
Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Circ Cardiovasc Qual Outcomes (2013) 0.78
The use of cholesterol-lowering medications after coronary revascularization. CMAJ (2003) 0.76
Health care in Canada and the United States. N Engl J Med (1993) 0.75
A comparison of cardiovascular procedure use between the United States and Canada. Health Serv Res (1998) 0.75
Health care in Canada and the United States. N Engl J Med (1993) 0.75
Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action? Trans Am Clin Climatol Assoc (1996) 0.75
Health care in Canada and the United States. N Engl J Med (1993) 0.75
Health care for Americans in Canada. CMAJ (1993) 0.75
AAPS/RAPS/CAPRA collaborative program: exploring the challenges of drug regulation in a global environment: clinical concerns. AAPS PharmSci (2003) 0.75
Impact of selected geographical and clinical conditions on thrombolysis rate in myocardial infarction in three departments of France. Eur J Epidemiol (2001) 0.75
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med (1992) 18.74
Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science (1981) 10.62
The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90
The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med (1995) 6.49
Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med (1991) 6.16
UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull (2001) 5.89
Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol (1985) 5.67
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med (1996) 5.20
A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med (1995) 4.94
Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation (1997) 4.81
Diversity and depth-specific distribution of SAR11 cluster rRNA genes from marine planktonic bacteria. Appl Environ Microbiol (1997) 4.71
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia (2005) 4.45
Myocardial infarct size and ventricular function in rats. Circ Res (1979) 4.33
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1999) 3.90
Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest (1991) 3.82
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest (1988) 3.76
Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol (1994) 3.57
The causal links between stress and burnout in a longitudinal study of UK doctors. Lancet (2002) 3.45
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Lancet (2000) 3.39
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A (1989) 3.37
Control of lymphokine secretion by prostaglandins. Nature (1976) 3.34
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19
Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med (1997) 3.13
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci (1998) 3.01
Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol (1986) 3.00
T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A (1992) 2.98
Interaction of citrus juices with felodipine and nifedipine. Lancet (1991) 2.97
HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am J Pathol (1987) 2.91
Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science (1994) 2.79
Hemodynamic regulation: investigation by spectral analysis. Am J Physiol (1985) 2.79
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation (1994) 2.74
Increased pulse pressure and risk of heart failure in the elderly. JAMA (1999) 2.74
Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury. Arch Phys Med Rehabil (2000) 2.72
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. N Engl J Med (1992) 2.72
Promoter trapping identifies real genes in C. elegans. Mol Gen Genet (1998) 2.65
Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation (1997) 2.64
Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med (1993) 2.62
Ambulatory phlebectomy using the tumescent technique for local anesthesia. Dermatol Surg (1995) 2.57
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet (1997) 2.53
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med (1996) 2.49
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation (2000) 2.47
Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol (1991) 2.40
Impaired effective cortical connectivity in vegetative state: preliminary investigation using PET. Neuroimage (1999) 2.39
A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol (1985) 2.38
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A (1993) 2.35
An efficient algorithm for spectral analysis of heart rate variability. IEEE Trans Biomed Eng (1986) 2.31
Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA (1998) 2.28
Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res (1985) 2.23
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med (1998) 2.22
Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med (2001) 2.22
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation (1986) 2.22
Acute precipitants of congestive heart failure exacerbations. Arch Intern Med (2001) 2.11
The cerebellum may be directly involved in cognitive functions. Neurology (2002) 2.08
Noninvasive delineation of the effects of moderate aging on myocardial perfusion. J Nucl Med (1991) 2.07
Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A (1993) 2.03
Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. J Natl Cancer Inst (1995) 2.01
Expression of an Arabidopsis cryptochrome gene in transgenic tobacco results in hypersensitivity to blue, UV-A, and green light. Proc Natl Acad Sci U S A (1995) 1.96
Radiology report production times: voice recognition vs. transcription. Radiol Manage (2001) 1.95
Iraqi missile attacks on Israel. The association of mortality with a life-threatening stressor. JAMA (1995) 1.93
Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation (1985) 1.92
Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol (1994) 1.88
Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study. J Am Coll Cardiol (1998) 1.88
Children of depressed mothers: maternal strain and symptom predictors of dysfunction. J Abnorm Psychol (1987) 1.83
Isolated systolic hypertension : prognostic information provided by pulse pressure. Hypertension (1999) 1.83
Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord (1995) 1.83
Digoxin-quinidine interaction Pharmacokinetic evaluation. N Engl J Med (1979) 1.82
Recommendations for the control of Yersinia pestis infections. Recommendations from the CDC. Infect Control (1981) 1.81
BICAV: a block-iterative parallel algorithm for sparse systems with pixel-related weighting. IEEE Trans Med Imaging (2001) 1.79
Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med (1990) 1.77
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J (1999) 1.76
Regional studies in skin cancer. 2. Wet tropical and subtropical coasts of Queensland. Med J Aust (1966) 1.75
The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality. Circulation (1979) 1.75
Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr (1995) 1.73